Singapore markets closed

Adamis Pharmaceuticals Corporation (ADMP)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.1300+0.0300 (+2.73%)
At close: 4:00PM EDT
1.1300 0.00 (0.00%)
After hours: 07:55PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close1.1000
Open1.1000
Bid1.1200 x 2200
Ask1.1300 x 3100
Day's range1.0800 - 1.1500
52-week range0.3800 - 2.3400
Volume4,820,922
Avg. volume3,192,121
Market cap168.241M
Beta (5Y monthly)1.35
PE ratio (TTM)N/A
EPS (TTM)-0.6370
Earnings date18 Oct 2021 - 22 Oct 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Zacks

    Adamis (ADMP) Begins Dosing in COVID Oral Antiviral Study

    Adamis (ADMP) starts dosing patients in phase II/III study to evaluate its oral investigational antiviral for the treatment of COVID-19.

  • Business Wire

    Adamis Announces Results of 2021 Annual Meeting of Stockholders

    SAN DIEGO, July 19, 2021--Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) ("Adamis" or the "Company") today announced that based on the Inspector of Election’s certified results from the Company’s 2021 Annual Meeting of Stockholders (the "Annual Meeting"), each of the Company’s nominees – Howard C. Birndorf, Roshawn A. Blunt, Dennis J. Carlo, Ph.D., David J. Marguglio and Richard C. Williams – have been re-elected to the Board of Directors (the "Board"). According to the Inspector of Election’

  • Business Wire

    Adamis Urges Stockholders to Vote to Reelect the Company’s Board of Directors at Upcoming Annual Meeting on Friday, July 16th

    SAN DIEGO, July 13, 2021--Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) ("Adamis" or the "Company") today urged its valued stockholders to vote to reelect all five members of the Company’s Board of Directors (the "Board") at the upcoming Annual Meeting of Stockholders (the "Annual Meeting") on July 16, 2021. In addition, the Board issued the following statement: